Clinical trials: Pigmented Skin Lesion

Melanoma

Evaluation of Pigmented Skin Lesions With MelaFind(R) System

• Completed
• Age: All ages
• Phase 3
• Medical device
• Results posted

The purpose of this clinical trial is to demonstrate that MelaFind®, a new instrument that uses machine vision for non-invasive early detection of cutaneous pigmented malignant melanoma, is safe and effective.

Trial name

NCT00434057

Testing

MelaFind(R)

Where

2 sites in United States

Volunteers

1,383 people, healthy volunteers welcome

Sponsor

MELA Sciences, Inc.